Effect of intrauterine fetal programming on response to postnatal shaker stress in endothelial nitric oxide knockout mouse model

Am J Obstet Gynecol. 2009 Sep;201(3):301.e1-6. doi: 10.1016/j.ajog.2009.05.040. Epub 2009 Jul 26.

Abstract

Objective: To determine whether the intrauterine environment affects the postnatal vascular response to stress in a model of fetal programming induced by endothelial nitric oxide synthase deficiency.

Study design: Homozygous nitric oxide synthase knockout and wild-type controls were crossbred to obtain maternally and paternally derived heterozygous offspring. At 14 weeks of age, in vivo blood pressure measurements by telemetry, and in vitro carotid arteries vascular reactivity studies were performed in male offspring after subjecting them to shaker stress.

Results: Maternally derived heterozygous offspring, compared with paternally derived heterozygous offspring, had significantly higher systolic blood pressure, mean arterial blood pressure, and pulse pressure before, as well as after introduction of the shaker stress. The difference in the latter between maternally and paternally derived heterozygous offspring was accentuated after stress. Maternally derived heterozygous offspring also had significantly higher contractile responses to phenylephrine when compared with paternally derived heterozygous offspring, and this was abolished after incubation with L-NAME.

Conclusion: The adverse uterine environment affects the postnatal vascular response to stress.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Blood Pressure / physiology
  • Carotid Arteries / physiology
  • Endothelium, Vascular / physiology
  • Fetal Development / physiology*
  • Male
  • Mice
  • Mice, Knockout
  • Models, Animal
  • Nitric Oxide Synthase Type III / deficiency
  • Phenylephrine / pharmacology
  • Stress, Physiological
  • Vasoconstriction / physiology*
  • Vasoconstrictor Agents / pharmacology
  • Vibration

Substances

  • Vasoconstrictor Agents
  • Phenylephrine
  • Nitric Oxide Synthase Type III
  • Nos3 protein, mouse